Title:
【発明の名称】がん細胞の多剤耐性を消失させるための薬剤
Document Type and Number:
Japanese Patent JP3186759
Kind Code:
B2
Abstract:
A compound comprising toremifene or its metabolite N-demethyltoremifene or 4-hydroxytoremifene, or a non-toxic pharmaceutically acceptable salt thereof may be used for the reversal of multidrug resistance of cancer cells to cytotoxic drugs in the treatment of cancer with at least one cytotoxic drug.
More Like This:
| WO/2011/110608 | TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE WITH MASITINIB |
| JPS54148709 | GLYCERIDE STRUCTUAL HOMOLOGUE AND ITS MANUFACTURE |
| WO/2017/147335 | BACTERIAL EFFLUX PUMP INHIBITORS |
Inventors:
Adrian Leverin Harris
Lauri Veiko Match Cangas
Michael William Degregorio
Lauri Veiko Match Cangas
Michael William Degregorio
Application Number:
JP22092690A
Publication Date:
July 11, 2001
Filing Date:
August 21, 1990
Export Citation:
Assignee:
Adrian Leverin Harris
Lauri Veiko Match Cangas
Michael William Degregorio
Lauri Veiko Match Cangas
Michael William Degregorio
International Classes:
A61K31/13; A61K31/135; A61K31/70; A61K31/7028; A61K31/7034; A61K31/704; A61K45/00; A61P35/00; A61P43/00; C07H15/244; (IPC1-7): A61K31/13; A61K45/00
Attorney, Agent or Firm:
Sota Asahina (2 outside)
Previous Patent: 携帯端末装置
Next Patent: SIMULTANEOUS ANALYSIS OF BENZOIC ACID, SORBIC ACID AND DEHYDROACETIC ACID
Next Patent: SIMULTANEOUS ANALYSIS OF BENZOIC ACID, SORBIC ACID AND DEHYDROACETIC ACID